Skip to content
Recall Observatory FDA recall evidence

Device product

Alinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the simultaneous qualitative detection and differentiation of RNA from SARS-CoV-2, influenza A virus (flu A), influenza B virus (flu B), and/or Respiratory Syncytial Virus (RSV) in anterior nasal or nasopharyngeal swab specimens collected by a healthcare provider (HCP), or in anterior nasal swab specimens that are self-collected at a healthcare location, from individuals suspected by their HCP of respiratory viral infection consistent with COVID-19.

Z-1749-2025

April 28, 2025

Class II

Product summary

Firm
Abbott Molecular, Inc.
Event
Event 96790
Status
Ongoing
Classification
Class II
Quantity
656 units
Official record key
device-enforcement:Z-1749-2025

Official wording

Reason: There were reports of an increase in reactive negative controls and false positive results.

Code information: UDI-DI: 00884929049390; Lot Number: 409384

Distribution pattern: Worldwide - US Nationwide distribution.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    There were reports of an increase in reactive negative controls and false positive results.